CLINICAL UTILITY OF AXUMIN PET/MRI IMAGING TWO YEARS FOLLOWING FOCAL CRYO-ABLATION (FCA) OF PROSTATE CANCER

{{header-clinical-trials-navigation}} CLINICAL UTILITY OF AXUMIN PET/MRI IMAGING TWO YEARS FOLLOWING FOCAL CRYO-ABLATION (FCA) OF PROSTATE CANCER Condition: Prostate Cancer Study Type: Interventional Clinical Trials Identifier NCT 8-digits: NCT04009083 Sponsor: NYU Langone Health Eligibility: Age: minimum 18 Years maximum 100 Years Gender: Male Inclusion Criteria: FCA at NYU Langone Health performed at least two years prior […]

Update: COVID19 Resources for Urologists

The EAU is a strong and diverse community and we can learn from each other so that we can make the best decisions for our patients in this challenging time. While many of our colleagues and members are working on the front line to respond to the pandemic, the EAU is working to provide easy […]

New ESU e-course on advanced PCa debuts

The European School of Urology (ESU) announced the latest addition to its digital activities, the e-course series “Advanced Prostate Cancer”, which was developed under the guidance and expertise of the Main Coordinator and esteemed Chair of the EAU PCa Guidelines Panel, Prof. Dr. Nicolas Mottet (FR). The series is comprised of five online courses encapsulating […]

Myths and realities: Infectious complications after endoscopic surgery of urinary stones

Figure 1: PCNL ultrasound stone fragmentation Over the last 20 years, the minimally invasive approach has been the gold standard in the management of patients affected by urinary stones. Ureteroscopy (URS), retrograde intrarenal surgery (RIRS) and percutaneous nephrolithotripsy (PCNL) have been successfully introduced in clinical practice, although severe complications – such as the risk of […]

X